Health Catalyst Capital

Represented Health Catalyst Capital, a venture capital fund focusing on healthcare technology and technology enabled services, in connection with its investment in the Series B-1 Preferred Stock of PierianDx, Inc., which is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases.